346 related articles for article (PubMed ID: 32793418)
1. Diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: A single centre experience.
Maguolo A; Rodella G; Dianin A; Nurti R; Monge I; Rigotti E; Cantalupo G; Salviati L; Tucci S; Pellegrini F; Molinaro G; Lupi F; Tonin P; Pasini A; Campostrini N; Ion Popa F; Teofoli F; Vincenzi M; Camilot M; Piacentini G; Bordugo A
Mol Genet Metab Rep; 2020 Sep; 24():100632. PubMed ID: 32793418
[TBL] [Abstract][Full Text] [Related]
2. Clinical and genetic characteristics of patients with fatty acid oxidation disorders identified by newborn screening.
Kang E; Kim YM; Kang M; Heo SH; Kim GH; Choi IH; Choi JH; Yoo HW; Lee BH
BMC Pediatr; 2018 Mar; 18(1):103. PubMed ID: 29519241
[TBL] [Abstract][Full Text] [Related]
3. Genetic characteristics and follow-up of patients with fatty acid β-oxidation disorders through expanded newborn screening in a Northern Chinese population.
Wang S; Leng J; Diao C; Wang Y; Zheng R
J Pediatr Endocrinol Metab; 2020 May; 33(6):683-690. PubMed ID: 32447334
[TBL] [Abstract][Full Text] [Related]
4. Effects of fasting, feeding and exercise on plasma acylcarnitines among subjects with CPT2D, VLCADD and LCHADD/TFPD.
Elizondo G; Matern D; Vockley J; Harding CO; Gillingham MB
Mol Genet Metab; 2020; 131(1-2):90-97. PubMed ID: 32928639
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive test using palmitate in patients with suspected fatty acid oxidation defects: disease-specific acylcarnitine patterns can help to establish the diagnosis.
Janzen N; Hofmann AD; Schmidt G; Das AM; Illsinger S
Orphanet J Rare Dis; 2017 Dec; 12(1):187. PubMed ID: 29268767
[TBL] [Abstract][Full Text] [Related]
6. Diversity in the incidence and spectrum of organic acidemias, fatty acid oxidation disorders, and amino acid disorders in Asian countries: Selective screening vs. expanded newborn screening.
Shibata N; Hasegawa Y; Yamada K; Kobayashi H; Purevsuren J; Yang Y; Dung VC; Khanh NN; Verma IC; Bijarnia-Mahay S; Lee DH; Niu DM; Hoffmann GF; Shigematsu Y; Fukao T; Fukuda S; Taketani T; Yamaguchi S
Mol Genet Metab Rep; 2018 Sep; 16():5-10. PubMed ID: 29946514
[TBL] [Abstract][Full Text] [Related]
7. Very Long-Chain Acyl-CoA Dehydrogenase Deficiency: High Incidence of Detected Patients With Expanded Newborn Screening Program.
Remec ZI; Groselj U; Drole Torkar A; Zerjav Tansek M; Cuk V; Perko D; Ulaga B; Lipovec N; Debeljak M; Kovac J; Battelino T; Repic Lampret B
Front Genet; 2021; 12():648493. PubMed ID: 33986768
[TBL] [Abstract][Full Text] [Related]
8. Newborn screening for fatty acid oxidation disorders in a southern Chinese population.
Lin Y; Lin C; Lin B; Zheng Z; Lin W; Chen Y; Chen D; Peng W
Heliyon; 2024 Jan; 10(1):e23671. PubMed ID: 38187300
[TBL] [Abstract][Full Text] [Related]
9. Newborn Screening for Mitochondrial Carnitine-Acylcarnitine Cycle Disorders in Zhejiang Province, China.
Zhou D; Cheng Y; Yin X; Miao H; Hu Z; Yang J; Zhang Y; Wu B; Huang X
Front Genet; 2022; 13():823687. PubMed ID: 35360862
[No Abstract] [Full Text] [Related]
10. Newborn screening and molecular features of patients with multiple acyl-CoA dehydrogenase deficiency in Quanzhou, China.
Lin Y; Zhang W; Chen Z; Lin C; Lin W; Fu Q; Peng W; Chen D
J Pediatr Endocrinol Metab; 2021 May; 34(5):649-652. PubMed ID: 33823107
[TBL] [Abstract][Full Text] [Related]
11. Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study of 187 patients.
Baruteau J; Sachs P; Broué P; Brivet M; Abdoul H; Vianey-Saban C; Ogier de Baulny H
J Inherit Metab Dis; 2013 Sep; 36(5):795-803. PubMed ID: 23053472
[TBL] [Abstract][Full Text] [Related]
12. Follow-up of fatty acid β-oxidation disorders in expanded newborn screening era.
Janeiro P; Jotta R; Ramos R; Florindo C; Ventura FV; Vilarinho L; Tavares de Almeida I; Gaspar A
Eur J Pediatr; 2019 Mar; 178(3):387-394. PubMed ID: 30617651
[TBL] [Abstract][Full Text] [Related]
13. Newborn screening for medium-chain acyl-CoA dehydrogenase deficiency: regional experience and high incidence of carnitine deficiency.
Couce ML; Sánchez-Pintos P; Diogo L; Leão-Teles E; Martins E; Santos H; Bueno MA; Delgado-Pecellín C; Castiñeiras DE; Cocho JA; García-Villoria J; Ribes A; Fraga JM; Rocha H
Orphanet J Rare Dis; 2013 Jul; 8():102. PubMed ID: 23842438
[TBL] [Abstract][Full Text] [Related]
14. Recurrent ACADVL molecular findings in individuals with a positive newborn screen for very long chain acyl-coA dehydrogenase (VLCAD) deficiency in the United States.
Miller MJ; Burrage LC; Gibson JB; Strenk ME; Lose EJ; Bick DP; Elsea SH; Sutton VR; Sun Q; Graham BH; Craigen WJ; Zhang VW; Wong LJ
Mol Genet Metab; 2015 Nov; 116(3):139-45. PubMed ID: 26385305
[TBL] [Abstract][Full Text] [Related]
15. Infants suspected to have very-long chain acyl-CoA dehydrogenase deficiency from newborn screening.
Merritt JL; Vedal S; Abdenur JE; Au SM; Barshop BA; Feuchtbaum L; Harding CO; Hermerath C; Lorey F; Sesser DE; Thompson JD; Yu A
Mol Genet Metab; 2014 Apr; 111(4):484-92. PubMed ID: 24503138
[TBL] [Abstract][Full Text] [Related]
16. Screening and follow-up results of fatty acid oxidative metabolism disorders in 608 818 newborns in Jining, Shandong province.
Yang C; Shi C; Zhou C; Wan Q; Zhou Y; Chen X; Jin X; Huang C; Xu P
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 50(4):472-480. PubMed ID: 34704412
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of rare diseases detected by newborn screening in the Czech Republic.
David J; Chrastina P; Pešková K; Kožich V; Friedecký D; Adam T; Hlídková E; Vinohradská H; Novotná D; Hedelová M; Al Taji E; Holubová A; Skalická V; Macek M; Gaillyová R; Votava F
Cent Eur J Public Health; 2019 Jun; 27(2):153-159. PubMed ID: 31241292
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of bezafibrate in two patients with mitochondrial trifunctional protein deficiency.
Suyama T; Shimura M; Fushimi T; Kuranobu N; Ichimoto K; Matsunaga A; Takayanagi M; Murayama K
Mol Genet Metab Rep; 2020 Sep; 24():100610. PubMed ID: 32509533
[TBL] [Abstract][Full Text] [Related]
19. Newborn screening and genetic variation of medium chain acyl-CoA dehydrogenase deficiency in the Chinese population.
Li YY; Xu J; Sun XC; Li HY; Mu K
J Pediatr Endocrinol Metab; 2022 Oct; 35(10):1264-1271. PubMed ID: 36068006
[TBL] [Abstract][Full Text] [Related]
20. Management and diagnosis of mitochondrial fatty acid oxidation disorders: focus on very-long-chain acyl-CoA dehydrogenase deficiency.
Yamada K; Taketani T
J Hum Genet; 2019 Feb; 64(2):73-85. PubMed ID: 30401918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
